Registry to evaluate catheter-assisted procedures for structural heart disease
Official title: Interventional Structural Registry - LuEbeck
Run by University of Luebeck · NCT06977139 · Data updated 2026-11-12
This study looks at how catheter-assisted procedures affect people with structural heart disease to see how safe and effective they are over time.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 2000 (estimated) |
| Sponsor | University of Luebeck Academic / other |
| Locations | 1 site (Lübeck, Schleswig-Holstein) |
| Status | Recruiting |
| Started | September 11, 2021 |
| Main results expected | January 1, 2030 |
| Study ends | January 1, 2035 |
| Registry record updated | May 18, 2025 |
| Trial ID | NCT06977139 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this registry are individuals diagnosed with structural heart disease who can provide informed consent.
✕Probably not a fit
Patients under 18 years of age or those unable to provide consent will not benefit from this registry.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This registry aims to investigate the impact of catheter-assisted procedures on patients with structural heart disease, focusing on clinical morbidity and mortality. It will document various parameters, including underlying diseases, safety, and effectiveness of the procedures over time. The study will also evaluate the long-term prognosis of patients following these interventions, providing valuable insights into their outcomes and the effectiveness of concomitant therapies.
Why it matters
Potential benefit: If successful, this registry could enhance understanding of treatment outcomes for patients with structural heart disease, leading to improved care strategies.
How similar studies have gone: Other observational studies have shown success in evaluating catheter-assisted procedures, indicating that this approach is supported by prior research.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Structural heart disease Exclusion Criteria: * Patients without consent/information * Age ≤ 18 years
Where it's running
-
Universitätsklinikum Schleswig-Holstein
Lübeck, Schleswig-Holstein, Germany Recruiting
Study contacts
- Study coordinator: Ingo Eitel, Prof. Dr.
- Email: cvro@uksh.de
- Phone: +49 451 500 44501
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Mitral and Tricuspid Valve-in-Valve/Valve-in-Ring Registry in Asia-Pacific
This registry tracks people in Asia-Pacific who have had or will have valve-in-valve or valve-in-ring procedures for mitral or tricuspid valve disease to learn about outcomes and safety after these transcatheter approaches.
-
Ventricular Tachycardia in Structural Heart Disease: A Registry
This registry will track adults with structural heart disease who have VT or treated nonsustained VT to see how they are managed and what happens over time in real-world care in China.
-
Measuring how the right ventricle and pulmonary artery work together in valve disease
This project will test whether non-invasive heart imaging can match invasive catheter measurements of right ventricular–pulmonary artery coupling in adults with significant valvular heart disease.
-
Improving mapping techniques for heart rhythm disorder treatment
This study is testing a new mapping technique to help doctors better find and treat the heart areas causing dangerous heart rhythms in patients with structural heart disease.
-
Evaluating the need for cardiac MRI in patients with premature ventricular complexes
This study is trying to see if heart scans are really needed for people with premature ventricular complexes to find any hidden heart problems.
-
Prognosis prediction for patients with cardiovascular and cerebrovascular diseases using multi-omics
This study is trying to find out how different biological factors affect people with heart and brain blood vessel diseases to help doctors predict outcomes and personalize treatments for them.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.